Blueprint Medicines Corporation is a clinical-stage biopharmaceutical company that focuses on developing targeted therapies for patients with genomically defined diseases. Its pipeline includes drug candidates for various types of cancers and rare genetic diseases, with a strong emphasis on precision medicine.
Notification